Medical Condition

speech intelligibility

Total Trials

3

Recruiting Now

3

Trial Phases

Various

ClinicalMetric tracks all active clinical trials for speech intelligibility sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Top Sponsors

Phillip Gander 1 trial

Toronto Metropolitan University 1 trial

Stanford University 1 trial

NCT06860152

Recruiting

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

speech intelligibility

Cochlear Implant Speech in Noise Processing

Benefits of Choir for Older Adults With Unaddressed Hearing Loss (WP2)

Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device